- Home
- ZYME vs EE Comparison
ZYME vs EE Comparison
Compare ZYME & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- EE
- Stock Information
- Founded
- ZYME 2003
- EE 2003
- Country
- ZYME United States
- EE United States
- Employees
- ZYME N/A
- EE N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- ZYME Health Care
- EE Utilities
- Exchange
- ZYME Nasdaq
- EE Nasdaq
- Market Cap
- ZYME 968.5M
- EE 786.2M
- IPO Year
- ZYME 2017
- EE 2022
- Fundamental
- Price
- ZYME $14.81
- EE $24.37
- Analyst Decision
- ZYME Buy
- EE Buy
- Analyst Count
- ZYME 7
- EE 7
- Target Price
- ZYME $20.00
- EE $32.86
- AVG Volume (30 Days)
- ZYME 453.7K
- EE 515.8K
- Earning Date
- ZYME 08-07-2025
- EE 08-11-2025
- Dividend Yield
- ZYME N/A
- EE 1.31%
- EPS Growth
- ZYME N/A
- EE 18.98
- EPS
- ZYME N/A
- EE 1.33
- Revenue
- ZYME $122,867,000.00
- EE $987,637,000.00
- Revenue This Year
- ZYME $107.76
- EE $31.19
- Revenue Next Year
- ZYME $2.35
- EE $25.16
- P/E Ratio
- ZYME N/A
- EE $18.36
- Revenue Growth
- ZYME 95.94
- EE 9.86
- 52 Week Low
- ZYME $9.03
- EE $17.70
- 52 Week High
- ZYME $17.70
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- ZYME 62.78
- EE 49.60
- Support Level
- ZYME $13.48
- EE $24.15
- Resistance Level
- ZYME $15.35
- EE $25.17
- Average True Range (ATR)
- ZYME 0.58
- EE 0.70
- MACD
- ZYME 0.10
- EE 0.21
- Stochastic Oscillator
- ZYME 80.21
- EE 80.69
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.